3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Neoplasms
15
Breast Neoplasms
13
Stomach Neoplasms
12
Prostatic Neoplasms
12
Colorectal Neoplasms
11
Pancreatic Neoplasms
9
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Carcinoma, Hepatocellular
7
Endometrial Neoplasms
5
Colonic Neoplasms
4
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Polycystic Ovary Syndrome
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Esophageal Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Skin Neoplasms
2
Salivary Gland Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Peritoneal Neoplasms
2
Papillomavirus Infections
2
Obesity
2
Multiple Myeloma
2
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Staining and Labeling
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Observation
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Bosentan
1
Aminocaproic Acid
1
Amikacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hyperaldosteronism
×
Observation
×
Clear all
NCT07272187
2025-12-09
EURAGIL
Herlev Hospital
Recruiting
138 enrolled